BACKGROUND/AIM: in patients with resectable initial HCC >3 cm. PATIENTS AND METHODS: . Associations between FDG-PET findings and clinicopathological factors were analyzed. RESULTS: with alpha-fetoprotein improved preoperative prediction of MVI. CONCLUSION: is an independent prognostic biomarker in HCC >3 cm and, when combined with serum alpha-fetoprotein, may enhance prediction of MVI. These findings support incorporating metabolic imaging into preoperative risk models to guide management.
No takes yet. Share an insight, caveat, or question.
Ishikawa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: